Pluripotent cell lines and methods of use thereof

CPC - классификация

AA6A61A61KA61K3A61K35A61K35/A61K35/1A61K35/12CC1C12C12NC12N2C12N25C12N250C12N2500C12N2500/C12N2500/2C12N2500/25C12N2500/4C12N2500/46C12N2501C12N2501/C12N2501/0C12N2501/01C12N2501/1C12N2501/11C12N2501/115C12N2501/119C12N2501/13C12N2501/15C12N2501/3C12N2501/39C12N2501/392C12N2501/4C12N2501/41C12N2501/5C12N2501/50C12N2501/6C12N2501/60C12N2501/602C12N2501/603C12N2501/604C12N2501/7C12N2501/70C12N2501/71C12N2503C12N2503/C12N2503/0C12N2503/02C12N2506C12N2506/C12N2506/1C12N2506/13C12N2506/130C12N2506/1307C12N2506/4C12N2506/45C12N27C12N274C12N2740C12N2740/C12N2740/1C12N2740/15C12N2740/150C12N2740/1503C12N2740/15032C12N5C12N5/C12N5/0C12N5/06C12N5/061C12N5/0619C12N7C12N7/C12N7/0C12N7/00C12QC12Q1C12Q1/C12Q1/6C12Q1/68C12Q1/688C12Q1/6883C12Q2C12Q26C12Q260C12Q2600C12Q2600/C12Q2600/1C12Q2600/13C12Q2600/136GG0G01G01NG01N2G01N23G01N233G01N2333G01N2333/G01N2333/4G01N2333/47G01N3G01N33G01N33/G01N33/5G01N33/50G01N33/502G01N33/5023G01N33/505G01N33/5058

IPC - классификация

AA6A61A61KA61K3A61K35A61K35/A61K35/1A61K35/12CC1C12C12NC12N5C12N5/C12N5/0C12N5/06C12N5/061C12N5/0619C12N5/07C12N5/079C12N5/0793C12N7C12N7/C12N7/0C12N7/00C12QC12Q1C12Q1/C12Q1/6C12Q1/68C12Q1/688C12Q1/6883GG0G01G01NG01N3G01N33G01N33/G01N33/5G01N33/50

Цитирование НПИ

Adewumi et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology. 2007;25:803-816.
Amir, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. Oct. 1999;23(2):185-8.
Andreotti, et al. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res. Nov. 15, 1995;55(22):5276-82.
Aoi et al. Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells. Science. Aug. 1, 2008;321(5889):699-702.
Beckers, et al. Application of intracellular ATP determination in lymphocytes for HLA-typing. J Biolumin Chemilumin. Sep. 1986;1(2):47-51.
Bongso, et al. Improved quality of human embryos when co-cultured with human ampullary cells. Hum Reprod. 1989; 4(6): 706-713.
Brooks, et al. Astrocytes as a primary locus for the conversion MPTP into MPP+. J Neural Transm. 1989;76(1):1-12.
Brooks, et al. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. Mar. 27, 1999;823(1-2):1-10.
Chamberlain, et al. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics. Oct. 2008;9(4):227-35.
Chartier-Harlin et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. The Lancet. 2004;364(9440):1167-1169.
Crouch, et al. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods. Mar. 15, 1993;160(1):81-8.
D'Amato, et al., Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP+ Binds to Neuromelanin. Science. Feb. 28, 1986;231(4741):987-9.
Daley, et al. Prospects for stem cell-based therapy. Cell. Feb. 22, 2008;132(4):544-8.
Deb-Rinker et al. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. The Journal of biological chemistry. 2005;(280):6257-6260.
Decipher v5.0. Available at https://decipher.sanger.ac.uk. Accessed Sep. 22, 2010.
Di Monte, et al. Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity. Biochem Biophys Res Commun. May. 29, 1986;137(1):303-9.
Di Monte, et al. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes. Glia. 1992;5(1):48-55.
Dorsey, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. Jan. 30, 2007;68(5):384-6.
Evans, et al. Early onset seizures and Rett-like features associated with mutations in CDKLS. Eur J Hum Genet. Oct. 2005;13(10):1113-20.
Farrer. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. Apr. 2006;7(4):306-18.
Filipov, et al. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. Toxicology. Mar. 22, 2007;232(1-2):68-78. Epub Dec. 15, 2006.
Formon, et al. Nosology of Parkinson's disease: looking for the way out of a quagmire. Neuron. Aug. 18, 2005;47(4):479-82.
Fuchs et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007;68, 916-922.
Gardner, et al. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. Jan. 1998;69(1):84-8.
Hanna, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. Dec. 21, 2007;318(5858):1920-3.
Hazell, et al., 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Decreases Glutamate Uptake in Cultured Astrocytes. J Neurochem. May 1997;68(5):2216-9.
Ibáñez et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. The Lancet. 2004;364(9440):1169-1171.
International search report dated Feb. 17, 2010 for PCT Application No. US2009/003783.
Joutel et al. Notch 3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707-710.
Kaelin. von Hippel-Lindau disease. Annual Review of Pathology. 2007;2:145-173.
Kehrer-Sawatzki. What a difference a copy number variation makes. BioEssays. 2007;29:311-313.
Kopin. Features of the dopaminergic neurotoxin MPTP. Ann N Y Acad Sci. May 11, 1992;648:96-104.
Langer. New methods of drug delivery. Science. Sep. 28, 1990;249(4976):1527-33.
Langston. The Parkinson's Complex: Parkinsonism is just the tip of the iceberg. Annals of Neurology. Apr. 2006; 59(4):591-596.
Litvan, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. Apr. 2007;66(4):251-7.
Litvan, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. May 2007;66(5):329-36.
Lowry et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. Feb. 26, 2008;105(8):2883-8.
Lupski. Genome structural variation and sporadic disease traits. Nat Genet. Sep. 2006;38(9):974-6.
Marchetto, et al. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet. Oct. 15, 2011;20(R2):R109-15. doi: 10.1093/hmg/ddr336. Epub Aug. 9, 2011.
Masaki et al. Tendency of pluripotential marker gene expression in colonies derived from human neonatal fibroblasts induced by the human iPS cell method. Stem Cell Research. 2008. doi:10.1016/j.scr.2008.01.001.
McNaught, et al., Effects of Isoquinoline Derivatives Structurally Related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on Mitochondrial Respiration. Biochem Pharmacol. Jun. 14, 1996;51(11):1503-11.
Muhle, et al. The genetics of autism. Pediatrics. May 2004;113(5):e472-86.
Murry et al. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661-680.
Nakagawa et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101-106.
Nicklas, et al., MPTP, MPP+ and Mitochondrial Function, Life Sci. 1987; 40:721-29.
Nilaver, et al. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci U S A. Oct. 10, 1995;92(21):9829-33.
Notice of allowance dated Dec. 17, 2013 for U.S Appl. No. 12/459,019.
Notice of allowance dated Oct. 10, 2013 for U.S Appl. No. 12/459,019.
O'Brien, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. Sep. 2000;267(17):5421-6.
Office action dated Jun. 27, 2011 for U.S Appl. No. 12/459,019.
Office action dated May 24, 2013 for U.S Appl. No. 12/459,019.
Office action dated Nov. 16, 2012 for U.S. Appl. No. 12/459,019.
Office action dated Sep. 22, 2011 for U.S Appl. No. 12/459,019.
Outeiro, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. Jul. 27, 2007;317(5837):516-9.
PDGene. Available at www.pdgene.org. Accessed Sep. 22, 2010.
Park et al. Disease-Specific Induced Pluripotent Stem Cells. Cell. 2008;134(5):877-886.
Park et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. Jan. 10, 2008;451(7175):141-6.
Park, et al. Efficient generation of dopamine neurons from human embryonic stem cells. Methods Mol Biol. 2007;407:311-22.
Pellecchia, et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology. 2005; 64 (10): 1810-2.
Peng, et al. Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration. J Neurosci. Nov. 8, 2006;26(45):11644-51.
Redon et al. Global variation in copy number In the human genome. Nature. 2006;23:444-454.
Reubinoff, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. Apr. 2000;18(4):399-404.
Riss, et al. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol. Feb. 2004;2(1):51-62.
Rubin, L. Stem cells and drug discovery: the beginning of a new era? Cell. Feb. 22, 2008;132(4):549-52.
Sebat et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445-459.
Singleton et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.
Smeyne, et al. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia. Glia. Apr. 15, 2001;34(2):73-80.
Soldner et al. (Cell, 136: 964-977, 2009) (Year: 2009).
Soldner et al. Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors. Cell. 2009;136(5):964-977.
Solter, et al. Immunosurgery of mouse blastocyst. Proc Natl Acad Sci U S A. Dec. 1975;72(12):5099-102.
Szatmari et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics. 2007;39(3):319-328.
Tagami, et al. Processes of beta-amyloid and intracellular cytoplasmic domain generation by presenilin/gamma-secretase. Neurodegener Dis. 2008;5(3-4):160-2.
Takahashi et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. Nov. 30, 2007;131(5):861-72.
Takahashi, et al., “Induction of Pluripotent Stem Cells From Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors,” Cell 126(41:663-676 (2006).
Thomas, et al. The Wilson disease gene: spectrum of mutations and their consequences, Nat Genet. 1995; 9(2):210-7.
Thomson et al. Embryonic stem cell lines derived from human blastocysts. Science. Nov. 6, 1998;282(5391):1145-7.
Thomson, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. Aug. 15, 1995;92(17):7844-8.
Thomson, et al. Primate embryonic stem cells. Curr. Top. Dev. Biol. 1998; 38:133-165.
Treat, et al. Liposomes in the Therapy of infectious Disease and Cancer, Lopez-Berestein and Fidler (eds.), Liss, New York, pp. pp. 317-327 and 353-365 (1989).
U.S. Appl. No. 14/098,890, filed Dec. 6, 2013.
Velculescu, et al. Serial analysis of dream expression. Science. 1995; 270:484-487.
Wernig et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318-324.
Willard, et al. Breaking the silence in Rett syndrome. Nat Genet. Oct. 1999;23(2):127-8.
Wisniewski, et al.Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun. Apr. 30, 1993;192(2):359-65.
Wood-Kaczmar, et al. Understanding the molecular causes of Parkinson's disease. Trends Mol Med. Nov. 2006;12(11):521-8.
Wszolek et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Annals of Neurology. 1992. 32(3):312-320.
Xia et al (Nature. Scientific Reports. Feb. 4, 2016; 6: 20270). (Year: 2016).
Yan, et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells. Jun.-Jul. 2005;23(6):781-90.
Yu et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. Dec. 21, 2007;318(5858):1917-20.